I-131-S-1
SODIUM IODIDE (131|)
| Name | SODIUM IODIDE (131I) CIS bio International |
| Pharmaceutical form | Oral solution |
| Nuclide | Iodine 131 |
| Half life | 8.02 days |
| Availability | Tuesday |
| Ordering deadline | Friday, before 11 a.m. |
| Radioactive concentration | 1110 MBq/mL at calibration date |
| Calibration | Wednesday (following week) 12 a.m. |
| Precalibred quantities | From 1110 to 11 100 MBq |
| Expiry | 29 days from the manufacturing date |
| Specific activity | ≥ 185 GBq/mg iodine |
| Radiochemical purity | Iodide : ≥ 95 % ; Iodate + periodate ≤ 5% |
| Radionuclidic purity | ≥ 99.9 %; 133I + 135I + other alpha impurities ≤ 0.1 % |
| pH and composition | 7 - 10 in sterile solution with carbonate-thiosulfate buffer |
| Storage | Not above 25°C |
| Indication | Diagnostic • Estimation of thyroid uptake and effective half life • Identification of thyroid remnant and metastases (after ablation) Therapy • Treatment of Graves disease, toxic multinodular goitre or autonomous nodules • Treatment of papillary and follicular thyroid carcinoma including metastatic disease |
Support Solution
IBA does not provide pharmaceuticals... we do much more than that. Beyond the quality of our products and services you expect a leading radiopharmaceutical company to provide you with all the environment necessary to master our products and to operate your daily activity in a professional manner.
Our set of customer solutions includes :
- Product trainings
- Round tables facilitation
- Patient recruitment support
- ISS (Investigator Sponsored Studies)
- Organisations of symposiums
- Newsletters
Product Calendar
SPC
For all other countries, please contact your local representative.
